Stay updated with breaking news from Gene Targeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA technology platform at the American Society of Gene Cell Therapy ASGCT 27th Annual Meeting being held May 711 2024 in Baltimore Maryland.
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the
This novel editing approach might unlock new strategies for the treatment of metabolic and neurological diseasesNon-viral circular ssDNA delivery associated to TALEN® gene editing allows high...
NEW YORK, April 08, 2024 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that...
/PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced in vivo data...